hodgkin disease
Showing NaN - NaN of 8
Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in Worldwide (pembrolizumab, Favezelimab)
Recruiting
- Hodgkin Disease
- +2 more
- pembrolizumab
- Favezelimab
-
Gilbert, Arizona
- +24 more
Aug 18, 2022
Hodgkin Disease Trial in Worldwide (Nivolumab, brentuximab vedotin, bendamustine)
Active, not recruiting
- Hodgkin Disease
- Nivolumab
- +2 more
-
Birmingham, Alabama
- +77 more
Jul 21, 2022
Hodgkin Disease Trial in Worldwide (Nivolumab, Doxorubicin, Vinblastine)
Active, not recruiting
- Hodgkin Disease
- Nivolumab
- +3 more
-
Los Angeles, California
- +37 more
Oct 25, 2021
Hodgkin Disease Trial in United States (brentuximab vedotin, bendamustine)
Completed
- Hodgkin Disease
- brentuximab vedotin
- bendamustine
-
Birmingham, Alabama
- +12 more
Jan 24, 2019
Non Hodgkin's Lymphoma, Hodgkin Disease, Multiple Myeloma Trial in Boston (Fludarabine and total body irradiation, Total body
Terminated
- Non Hodgkin's Lymphoma
- +2 more
- Fludarabine and total body irradiation
- Total body irradiation
-
Boston, MassachusettsMassachusetts General Hospital
Mar 26, 2018
Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Boston (Haploidentical Bone
Unknown status
- Chronic Kidney Disease
- +16 more
- Haploidentical Bone Marrow/Kidney
-
Boston, MassachusettsMassachusetts General Hospital
Mar 21, 2017
Leukemia, Myeloid, Chronic, Anemia, Aplastic, Myelofibrosis Trial in Gainesville, Boston (Parathyroid Hormone (teriparatide))
Terminated
- Leukemia, Myeloid, Chronic
- +7 more
- Parathyroid Hormone (teriparatide)
-
Gainesville, Florida
- +3 more
Apr 22, 2013
Hodgkin Disease, Lymphoma, Large-Cell, Sarcoma, Kaposi Trial in United States (SGN-30 (mAb))
Completed
- Hodgkin Disease
- +4 more
- SGN-30 (monoclonal antibody)
-
Birmingham, Alabama
- +9 more
Oct 7, 2011